NASDAQ: VXRTVaxart Revenue
Vaxart revenue was $28.70M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $15.2M, up 207.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VXRT annual revenue was $28.7M, with 288.9% growth year-over-year.
VXRT past revenue growth
How has VXRT's revenue growth performed historically?
Company
288.94%
Industry
497.69%
Market
20.68%
VXRT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VXRT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VXRT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
VXRT revenue history
Current Revenue
$28.7M
Current Earnings
-$66.9M
Current Profit Margin
-233.3%
Be the first to know when VXRT announces revenue.
VXRT Revenue History By Year
| VXRT Yearly Revenue | VXRT Revenue | VXRT Change | VXRT Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $28.70M | $21.32M | +288.94% |
| 2023-12-31 | $7.38M | $7.27M | +6,796.26% |
| 2022-12-31 | $107.00k | -$785.00k | -88.00% |
| 2021-12-31 | $892.00k | -$3.15M | -77.95% |
| 2020-12-31 | $4.05M | -$5.82M | -58.97% |
| 2019-12-31 | $9.86M | $5.70M | +137.12% |
| 2018-12-31 | $4.16M | -$1.68M | -28.77% |
| 2017-12-31 | $5.84M | -$3.46M | -37.22% |
| 2016-06-30 | $9.30M | -$15.30M | -62.20% |
| 2015-06-30 | $24.60M | -$44.10M | -64.19% |
| 2014-06-30 | $68.70M | $35.10M | +104.46% |
| 2013-06-30 | $33.60M | $13.20M | +64.71% |
| 2012-06-30 | $20.40M | $7.90M | +63.20% |
| 2011-06-25 | $12.50M | -$22.51M | -64.29% |
| 2010-12-25 | $35.01M | $24.52M | +233.73% |
| 2009-12-26 | $10.49M | N/A | N/A |
| 2008-12-27 | $0.00 | N/A | N/A |
| 2007-12-29 | $0.00 | N/A | N/A |
| 2006-12-30 | $0.00 | N/A | N/A |
| 2005-12-31 | $0.00 | -$142.18M | -100.00% |
| 2004-12-25 | $142.18M | -$34.39M | -19.47% |
| 2003-12-27 | $176.57M | -$19.40M | -9.90% |
| 2002-12-28 | $195.97M | -$38.86M | -16.55% |
| 2001-12-29 | $234.83M | $6.05M | +2.64% |
| 2000-12-30 | $228.78M | -$4.82M | -2.06% |
| 1999-12-31 | $233.60M | -$9.48M | -3.90% |
| 1998-12-31 | $243.09M | $14.34M | +6.27% |
| 1997-12-31 | $228.74M | -$11.17M | -4.65% |
| 1996-12-31 | $239.91M | $43.98M | +22.45% |
| 1995-12-31 | $195.93M | $31.50M | +19.16% |
| 1994-12-31 | $164.43M | N/A | N/A |
Vaxart Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.